Bacterial Host Cell Plasmid Stability via Alanine Racemase

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Recombinant production hosts in bacterial fermentation processes face challenges with plasmid instability and metabolic burden, leading to reduced productivity due to outgrowth of wild-type cells and loss of plasmids, especially under conditions of high compound production, where antibiotic resistance markers are ineffective and auxotrophic markers can be detrimental to cell growth.

Innovation Solution

Inactivating both chromosomal genes encoding alanine racemases in a bacterial host cell and introducing a plasmid with an autonomous replication sequence, a polynucleotide encoding a polypeptide of interest, and a third alanine racemase operably linked to a promoter, to enhance plasmid stability and polypeptide expression.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If antibiotic resistance markers are used for plasmid selection, then plasmid maintenance is achieved, but the system becomes ineffective under long-term cultivation due to antibiotic degradation and dilution, and requires additional purification steps

Engineering Contradiction:
Improveplasmid maintenanceVSAvoidproduct yield
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent removes antibiotic resistance markers from the plasmid system and replaces them with an auxotrophic marker (purF gene). This extraction of the harmful antibiotic dependency while retaining plasmid maintenance functionality resolves the contradiction between reliable plasmid maintenance and productivity.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent uses a metabolic pathway (purine biosynthesis) that is naturally essential for cell survival but can be supplemented in the growth medium. The auxotrophic marker provides continuous selective pressure without requiring persistent antibiotic presence, effectively replacing a long-lived selection mechanism with a metabolically-based one that works throughout cultivation.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Reliability

If auxotrophic markers are used on multi-copy plasmids for positive selection, then plasmid maintenance is achieved, but cell growth and productivity are negatively impacted due to unbalanced enzymatic function

Engineering Contradiction:
Improveplasmid maintenanceVSAvoidcell growth and productivity
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent applies local quality by providing the purF gene product (phosphoribosylformylglycinamidine synthase) specifically where needed - in plasmid-carrying cells - to balance the purine biosynthesis pathway. This localized supplementation allows auxotrophic selection without globally disrupting cellular metabolism, resolving the contradiction between plasmid maintenance and cell growth.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent changes the selection mechanism from antibiotic-based to metabolism-based, utilizing the purine biosynthesis pathway. By modifying the metabolic state of the cell (creating a purine auxotroph) rather than imposing external chemical selection, the system achieves plasmid maintenance while minimizing impact on overall cellular physiology and productivity.

Inventive Principle:
Principle #35Parameter changes

3Stability of the object's composition

If chromosomal genes are deleted to create auxotrophic markers, then plasmid stability is improved, but the system becomes less effective when cell lysis occurs due to cross-feeding

Engineering Contradiction:
Improveplasmid stabilityVSAvoidauxotrophic marker effectiveness
Core Design Contradiction:
Stability of the object's compositionVSReliability

Solution Approach 1:

The patent uses D-alanine as an intermediary substance that mediates between plasmid stability and auxotrophic marker effectiveness. The dal gene on the plasmid encodes D-alanine racemase, which produces D-alanine to compensate for the deleted chromosomal dal gene. This intermediary metabolite ensures continuous selection pressure even when cell lysis occurs, maintaining both plasmid stability and marker reliability.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Productivity

If recombinant production hosts are genetically modified for high-level compound production, then productivity is improved, but fitness decreases leading to outgrowth of wild-type cells and loss of plasmids

Engineering Contradiction:
Improvecompound productionVSAvoidhost cell fitness
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies preliminary action by pre-modifying the host cell genome to delete the chromosomal dal gene before introducing the plasmid. This creates a dependency on the plasmid-carrying dal gene, ensuring that recombinant hosts with high productivity traits are selectively maintained. The preliminary genetic modification establishes a selection system that automatically favors productive recombinant strains over wild-type cells throughout fermentation.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS20230295603A1Alanine racemase double deletion and transcomplementation
Publication Date: 2023.09.21 BASF SE
  • US20230295603A1 patent drawing

AI summary

The present invention relates to a bacterial host cell in which a first chromosomal gene encoding a first alanine racemase and a second chromosomal gene encoding a second alanine racemase have been inactivated. Said bacterial host cell comprises – either on a plasmid comprising at least one autonomous replication sequence or present as multiple copies in the chromosome – a gene expression cassette comprising a polynucleotide encoding at least one polypeptide of interest, operably linked to a promoter, and a polynucleotide encoding a third alanine racemase, operably linked to a promoter. The present invention further relates to a method for producing at least one polypeptide of interest based on cultivating the bacterial host cell of the present invention.